nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00903	0.291	CbGbCtD
Darifenacin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00839	0.271	CbGbCtD
Darifenacin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00385	0.124	CbGbCtD
Darifenacin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00379	0.122	CbGbCtD
Darifenacin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00353	0.114	CbGbCtD
Darifenacin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00241	0.0777	CbGbCtD
Darifenacin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Darifenacin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Darifenacin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Darifenacin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00135	0.0014	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00135	0.0014	CcSEcCtD
Darifenacin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00139	CcSEcCtD
Darifenacin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00134	0.00139	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00134	0.00139	CcSEcCtD
Darifenacin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00138	CcSEcCtD
Darifenacin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00138	CcSEcCtD
Darifenacin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00133	0.00138	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00137	CcSEcCtD
Darifenacin—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00136	CcSEcCtD
Darifenacin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Darifenacin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Darifenacin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Darifenacin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Darifenacin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Darifenacin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00134	CcSEcCtD
Darifenacin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00129	0.00134	CcSEcCtD
Darifenacin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Rash—Topotecan—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00128	0.00133	CcSEcCtD
Darifenacin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00132	CcSEcCtD
Darifenacin—Cough—Etoposide—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Headache—Topotecan—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00132	CcSEcCtD
Darifenacin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Darifenacin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Darifenacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Darifenacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Darifenacin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Darifenacin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Darifenacin—Pain—Vincristine—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Darifenacin—Constipation—Vincristine—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Darifenacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Darifenacin—Fexofenadine—ABCB1—peripheral nervous system neoplasm	0.00126	0.284	CrCbGaD
Darifenacin—Rash—Melphalan—peripheral nervous system neoplasm	0.00125	0.0013	CcSEcCtD
Darifenacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00125	0.0013	CcSEcCtD
Darifenacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00129	CcSEcCtD
Darifenacin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00129	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00123	0.00128	CcSEcCtD
Darifenacin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00127	CcSEcCtD
Darifenacin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00126	CcSEcCtD
Darifenacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00121	0.00126	CcSEcCtD
Darifenacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Darifenacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Darifenacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.0012	0.00125	CcSEcCtD
Darifenacin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.0012	0.00125	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00124	CcSEcCtD
Darifenacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0012	0.00124	CcSEcCtD
Darifenacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.00124	CcSEcCtD
Darifenacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00119	0.00124	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00123	CcSEcCtD
Darifenacin—Infection—Etoposide—peripheral nervous system neoplasm	0.00118	0.00123	CcSEcCtD
Darifenacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00123	CcSEcCtD
Darifenacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00118	0.00122	CcSEcCtD
Darifenacin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00122	CcSEcCtD
Darifenacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00116	0.00121	CcSEcCtD
Darifenacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00116	0.00121	CcSEcCtD
Darifenacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00116	0.0012	CcSEcCtD
Darifenacin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00116	0.0012	CcSEcCtD
Darifenacin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.0012	CcSEcCtD
Darifenacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Darifenacin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00118	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Darifenacin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Darifenacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Darifenacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00116	CcSEcCtD
Darifenacin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Darifenacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00114	CcSEcCtD
Darifenacin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00113	CcSEcCtD
Darifenacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00108	0.00112	CcSEcCtD
Darifenacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00112	CcSEcCtD
Darifenacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Darifenacin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Darifenacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00106	0.0011	CcSEcCtD
Darifenacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00106	0.0011	CcSEcCtD
Darifenacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00106	0.00109	CcSEcCtD
Darifenacin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Darifenacin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Darifenacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Darifenacin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Darifenacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00108	CcSEcCtD
Darifenacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00108	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00103	0.00107	CcSEcCtD
Darifenacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00106	CcSEcCtD
Darifenacin—Constipation—Etoposide—peripheral nervous system neoplasm	0.00102	0.00106	CcSEcCtD
Darifenacin—Pain—Etoposide—peripheral nervous system neoplasm	0.00102	0.00106	CcSEcCtD
Darifenacin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00106	CcSEcCtD
Darifenacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00105	CcSEcCtD
Darifenacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Darifenacin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.001	0.00104	CcSEcCtD
Darifenacin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.00103	CcSEcCtD
Darifenacin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000983	0.00102	CcSEcCtD
Darifenacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000982	0.00102	CcSEcCtD
Darifenacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000978	0.00101	CcSEcCtD
Darifenacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000975	0.00101	CcSEcCtD
Darifenacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000973	0.00101	CcSEcCtD
Darifenacin—Clotrimazole—ABCB1—peripheral nervous system neoplasm	0.000971	0.219	CrCbGaD
Darifenacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000971	0.00101	CcSEcCtD
Darifenacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.00101	CcSEcCtD
Darifenacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.00101	CcSEcCtD
Darifenacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000963	0.000998	CcSEcCtD
Darifenacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.000997	CcSEcCtD
Darifenacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000959	0.000994	CcSEcCtD
Darifenacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000957	0.000992	CcSEcCtD
Darifenacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000945	0.00098	CcSEcCtD
Darifenacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000943	0.000978	CcSEcCtD
Darifenacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000942	0.000977	CcSEcCtD
Darifenacin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000942	0.000977	CcSEcCtD
Darifenacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000936	0.00097	CcSEcCtD
Darifenacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000934	0.000968	CcSEcCtD
Darifenacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000934	0.000968	CcSEcCtD
Darifenacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000929	0.000964	CcSEcCtD
Darifenacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000929	0.000963	CcSEcCtD
Darifenacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000928	0.000962	CcSEcCtD
Darifenacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000927	0.000961	CcSEcCtD
Darifenacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000961	CcSEcCtD
Darifenacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000922	0.000956	CcSEcCtD
Darifenacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000922	0.000956	CcSEcCtD
Darifenacin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00091	0.000943	CcSEcCtD
Darifenacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000907	0.00094	CcSEcCtD
Darifenacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000906	0.00094	CcSEcCtD
Darifenacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00089	0.000923	CcSEcCtD
Darifenacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000889	0.000922	CcSEcCtD
Darifenacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000879	0.000911	CcSEcCtD
Darifenacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000878	0.000911	CcSEcCtD
Darifenacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000874	0.000906	CcSEcCtD
Darifenacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000905	CcSEcCtD
Darifenacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000864	0.000895	CcSEcCtD
Darifenacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000859	0.000891	CcSEcCtD
Darifenacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.000889	CcSEcCtD
Darifenacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000855	0.000887	CcSEcCtD
Darifenacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000853	0.000885	CcSEcCtD
Darifenacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000853	0.000884	CcSEcCtD
Darifenacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000848	0.000879	CcSEcCtD
Darifenacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000843	0.000874	CcSEcCtD
Darifenacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000839	0.000869	CcSEcCtD
Darifenacin—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.00083	0.188	CrCbGaD
Darifenacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000827	0.000858	CcSEcCtD
Darifenacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000824	0.000854	CcSEcCtD
Darifenacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.000853	CcSEcCtD
Darifenacin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00082	0.000851	CcSEcCtD
Darifenacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00082	0.00085	CcSEcCtD
Darifenacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000816	0.000846	CcSEcCtD
Darifenacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000813	0.000843	CcSEcCtD
Darifenacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000836	CcSEcCtD
Darifenacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000831	CcSEcCtD
Darifenacin—Loperamide—ABCB1—peripheral nervous system neoplasm	0.0008	0.181	CrCbGaD
Darifenacin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000792	0.000821	CcSEcCtD
Darifenacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.000819	CcSEcCtD
Darifenacin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000788	0.000817	CcSEcCtD
Darifenacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000784	0.000813	CcSEcCtD
Darifenacin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000773	0.000801	CcSEcCtD
Darifenacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000772	0.0008	CcSEcCtD
Darifenacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.00079	CcSEcCtD
Darifenacin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000758	0.000786	CcSEcCtD
Darifenacin—Rash—Etoposide—peripheral nervous system neoplasm	0.000752	0.000779	CcSEcCtD
Darifenacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000751	0.000779	CcSEcCtD
Darifenacin—Headache—Etoposide—peripheral nervous system neoplasm	0.000747	0.000774	CcSEcCtD
Darifenacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000774	CcSEcCtD
Darifenacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000769	CcSEcCtD
Darifenacin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000761	CcSEcCtD
Darifenacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000733	0.00076	CcSEcCtD
Darifenacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000724	0.00075	CcSEcCtD
Darifenacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00072	0.000746	CcSEcCtD
Darifenacin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000714	0.000741	CcSEcCtD
Darifenacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.00074	CcSEcCtD
Darifenacin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000708	0.000734	CcSEcCtD
Darifenacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000707	0.000733	CcSEcCtD
Darifenacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000697	0.000723	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000692	0.000718	CcSEcCtD
Darifenacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000682	0.000707	CcSEcCtD
Darifenacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000704	CcSEcCtD
Darifenacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000674	0.000699	CcSEcCtD
Darifenacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000694	CcSEcCtD
Darifenacin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000693	CcSEcCtD
Darifenacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000693	CcSEcCtD
Darifenacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000666	0.00069	CcSEcCtD
Darifenacin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000664	0.000688	CcSEcCtD
Darifenacin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000685	CcSEcCtD
Darifenacin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000682	CcSEcCtD
Darifenacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000655	0.000679	CcSEcCtD
Darifenacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000678	CcSEcCtD
Darifenacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000652	0.000676	CcSEcCtD
Darifenacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000649	0.000673	CcSEcCtD
Darifenacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000646	0.00067	CcSEcCtD
Darifenacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.000669	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000664	CcSEcCtD
Darifenacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000654	CcSEcCtD
Darifenacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.000646	CcSEcCtD
Darifenacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000641	CcSEcCtD
Darifenacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000641	CcSEcCtD
Darifenacin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000637	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000631	CcSEcCtD
Darifenacin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000631	CcSEcCtD
Darifenacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.000629	CcSEcCtD
Darifenacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000627	CcSEcCtD
Darifenacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000626	CcSEcCtD
Darifenacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000623	CcSEcCtD
Darifenacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.00062	CcSEcCtD
Darifenacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000596	0.000618	CcSEcCtD
Darifenacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000594	0.000616	CcSEcCtD
Darifenacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000588	0.00061	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000598	CcSEcCtD
Darifenacin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000571	0.000592	CcSEcCtD
Darifenacin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000571	0.000592	CcSEcCtD
Darifenacin—Methadone—ABCB1—peripheral nervous system neoplasm	0.000569	0.129	CrCbGaD
Darifenacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000584	CcSEcCtD
Darifenacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.00058	CcSEcCtD
Darifenacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000571	CcSEcCtD
Darifenacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000571	CcSEcCtD
Darifenacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00057	CcSEcCtD
Darifenacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000567	CcSEcCtD
Darifenacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.000564	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000553	CcSEcCtD
Darifenacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000548	CcSEcCtD
Darifenacin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000548	CcSEcCtD
Darifenacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000548	CcSEcCtD
Darifenacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000528	CcSEcCtD
Darifenacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000524	CcSEcCtD
Darifenacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000492	0.00051	CcSEcCtD
Darifenacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000507	CcSEcCtD
Darifenacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000497	CcSEcCtD
Darifenacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000473	0.00049	CcSEcCtD
Darifenacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000474	CcSEcCtD
Darifenacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000472	CcSEcCtD
Darifenacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.00046	CcSEcCtD
Darifenacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000458	CcSEcCtD
Darifenacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000454	CcSEcCtD
Darifenacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000425	0.00044	CcSEcCtD
Darifenacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000439	CcSEcCtD
Darifenacin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000437	CcSEcCtD
Darifenacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000436	CcSEcCtD
Darifenacin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000434	CcSEcCtD
Darifenacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000424	CcSEcCtD
Darifenacin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000412	CcSEcCtD
Darifenacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000408	CcSEcCtD
Darifenacin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000404	CcSEcCtD
Darifenacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000404	CcSEcCtD
Darifenacin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000402	CcSEcCtD
Darifenacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000381	CcSEcCtD
